Form 4: ChromaDex CEO Robert Fried Acquires Stock Options
SEC Form 4 Filing
ChromaDex Corp. CEO Robert N. Fried reports acquisition of employee stock options.
Summary
- Robert N. Fried, CEO of ChromaDex Corp., filed a Form 4 with the SEC.
- The filing reports a transaction on February 12, 2025, where Fried acquired 492,278 employee stock options with an exercise price of $5.48.
- These options vest over time, starting February 12, 2026, with one-third vesting initially and the remainder in 24 equal monthly installments.
- The options expire on February 11, 2035.
- Following the reported transaction, Fried directly owns 492,278 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock option grants, indicating a neutral sentiment.
Industry Context
This is a standard SEC filing related to insider transactions. It is common for executives to receive stock options as part of their compensation packages. The vesting schedule is also typical.
Stakeholder Impact
- The granting of stock options aligns management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of transaction: CEO Robert N. Fried acquired employee stock options. |
| 02/12/2026 | Vesting start date: One-third of the shares subject to the option vest. |
| 02/11/2035 | Expiration date of the employee stock options. |
| 02/14/2025 | Date of filing: Form 4 was signed on this date. |
Keywords
Form 4, ChromaDex, CDXC, Stock Options, Robert Fried, SEC Filing, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.